These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1050 related items for PubMed ID: 28185166

  • 1. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S, Paramasivam G, Mishra S.
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828
    [Abstract] [Full Text] [Related]

  • 3. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
    Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Peña C, Geraghty P, Lee A, White R, Clair DG.
    JACC Cardiovasc Interv; 2019 Dec 23; 12(24):2515-2524. PubMed ID: 31575518
    [Abstract] [Full Text] [Related]

  • 4. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A.
    JACC Cardiovasc Interv; 2016 May 09; 9(9):950-6. PubMed ID: 27151609
    [Abstract] [Full Text] [Related]

  • 5. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    JACC Cardiovasc Interv; 2013 Dec 09; 6(12):1295-302. PubMed ID: 24239203
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2016 Feb 09; 23(1):52-7. PubMed ID: 26511896
    [Abstract] [Full Text] [Related]

  • 7. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 09; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 8. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
    Herten M, Torsello GB, Schönefeld E, Stahlhoff S.
    Vasc Health Risk Manag; 2016 Sep 09; 12():341-56. PubMed ID: 27621646
    [Abstract] [Full Text] [Related]

  • 9. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):934-941. PubMed ID: 29730375
    [Abstract] [Full Text] [Related]

  • 10. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jul 28; 66():595-600. PubMed ID: 31863948
    [Abstract] [Full Text] [Related]

  • 11. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G.
    J Endovasc Ther; 2019 Feb 28; 26(1):26-30. PubMed ID: 30760132
    [Abstract] [Full Text] [Related]

  • 12. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, Cardenas J, Werner M, Brodmann M, Mustapha JA, Mena-Hurtado C, Jaff MR, Holden AH, Lyden SP.
    Circulation; 2017 Sep 19; 136(12):1102-1113. PubMed ID: 28729250
    [Abstract] [Full Text] [Related]

  • 13. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ.
    Am Heart J; 2015 Apr 19; 169(4):479-85. PubMed ID: 25819854
    [Abstract] [Full Text] [Related]

  • 14. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.
    J Endovasc Ther; 2014 Jun 19; 21(3):359-68. PubMed ID: 24915582
    [Abstract] [Full Text] [Related]

  • 15. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D.
    JACC Cardiovasc Interv; 2016 Apr 11; 9(7):715-24. PubMed ID: 27056311
    [Abstract] [Full Text] [Related]

  • 16. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
    Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T, IN.PACT Global Study Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):945-953. PubMed ID: 29798770
    [Abstract] [Full Text] [Related]

  • 17. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D, LEVANT 2 Investigators.
    N Engl J Med; 2015 Jul 09; 373(2):145-53. PubMed ID: 26106946
    [Abstract] [Full Text] [Related]

  • 18. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun 09; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 19. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
    Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D.
    J Endovasc Ther; 2016 Apr 09; 23(2):356-70. PubMed ID: 26823485
    [Abstract] [Full Text] [Related]

  • 20. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
    Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M, ILLUMENATE EU RCT Investigators.
    Circulation; 2017 Jun 06; 135(23):2227-2236. PubMed ID: 28424223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.